Federal Register
Title | Federal Register PDF eBook |
Author | |
Publisher | |
Pages | 292 |
Release | 2012-09 |
Genre | Delegated legislation |
ISBN |
Proceedings of the Fifth International Mobile Satellite Conference 1997, IMSC '97
Title | Proceedings of the Fifth International Mobile Satellite Conference 1997, IMSC '97 PDF eBook |
Author | Louise Anderson |
Publisher | |
Pages | 594 |
Release | 1997 |
Genre | Artificial satellites in telecommunication |
ISBN |
SEC Docket
Title | SEC Docket PDF eBook |
Author | United States. Securities and Exchange Commission |
Publisher | |
Pages | 1220 |
Release | 1997 |
Genre | Securities |
ISBN |
Thyroid Cancer
Title | Thyroid Cancer PDF eBook |
Author | Glenn D. Braunstein |
Publisher | Springer Science & Business Media |
Pages | 319 |
Release | 2011-11-09 |
Genre | Medical |
ISBN | 146140875X |
The American Cancer Society recently estimated that about 45,000 new cases of thyroid cancer will be diagnosed in the United States, with three-quarters occurring in women. The overall 5-year survival rate is about 97%, making it one of the least lethal cancers. We are experiencing an epidemic of well-differentiated thyroid cancer, in part due to the widespread use of imaging modalities that detect thyroid nodules and microcarcinomas. Concurrently, there have been a number of recent advances in surgical treatment, as well as diagnostic modalities that allow us to detect small amounts of residual local and metastatic disease. Additionally, a reexamination of past treatment regimens has led to new recommendations regarding the use of radioactive iodine, and to new therapeutic options, such as targeted therapy which have supplanted the use of more toxic chemotherapy for metastatic cancer. Multiple academic organizations have developed consensus guidelines for the management of thyroid cancer, occasionally with conflicting recommendations. In Thyroid Cancer, a renowned group of authors presents a broad overview of the pathology, pathophysiology, diagnosis, and management of thyroid cancer, with an emphasis on recent evidence-based information. State-of-the-art and a significant contribution to the literature, Thyroid Cancer is an invaluable reference for endocrinologists, oncologists, nuclear medicine physicians, radiation oncologists, primary care physicians, and surgeons who deal with head and neck cancer.
Thyroid Cancer
Title | Thyroid Cancer PDF eBook |
Author | H.-J. Biersack |
Publisher | Springer Science & Business Media |
Pages | 392 |
Release | 2005-06-10 |
Genre | Medical |
ISBN | 9783540223092 |
- Includes all current diagnostic techniques including FDG-PET and MRI - Second Edition is completely revised to include the latest diagnostic and theraputic concepts - Special section is devoted to medullary thyroid cancer
Hedgehog signaling activation in human cancer and its clinical implications
Title | Hedgehog signaling activation in human cancer and its clinical implications PDF eBook |
Author | Jingwu Xie |
Publisher | Springer Science & Business Media |
Pages | 223 |
Release | 2011-04-30 |
Genre | Medical |
ISBN | 1441984356 |
Understanding the role of hedgehog signaling in cancer is critically important for novel cancer therapeutics. The hedgehog pathway is a major pathway regulating cell differentiation, tissue polarity, stem cell maintenance and cell proliferation. It is known by now that activation of this pathway occurs in a variety of human cancer, including basal cell carcinomas (BCCs), medulloblastomas, leukemia, gastrointestinal, lung, ovarian, breast and prostate cancers. This book provides insightful views suitable for graduate students, medical students, undergraduate students, basic and clinical scientists, cancer patients as well as the general public.
Handbook of Therapeutic Antibodies
Title | Handbook of Therapeutic Antibodies PDF eBook |
Author | Stefan Dübel |
Publisher | John Wiley & Sons |
Pages | 2538 |
Release | 2014-08-04 |
Genre | Science |
ISBN | 3527682449 |
Still the most comprehensive reference source on the development, production and therapeutic application of antibodies, this second edition is thoroughly updated and now has 30% more content. Volume 1 covers selection and engineering strategies for new antibodies, while the second volume presents novel therapeutic concepts and antibodies in clinical study, as well as their potential. Volumes 3 and 4 feature detailed and specific information about each antibody approved for therapeutic purposes, including clinical data. This unique handbook concludes with a compendium of marketed monoclonal antibodies and an extensive index. Beyond providing current knowledge, the authors discuss emerging technologies, future developments, and intellectual property issues, such that this handbook meets the needs of academic researchers, decision makers in industry and healthcare professionals in the clinic.